Investor
H.C. Wainwright 23rd Annual Global Investment Conference
 Monday, September 13, 2021 -
Wednesday, September 15, 2021
 7:00am - 1:00pm EDT

Date:

Monday, September 13, 2021

 

Time:

Available on-demand starting at 7:00 a.m. Eastern Time (ET)

 

Moderator:

Vernon Bernardino

 

Novavax participants:

Gregory M. Glenn, M.D., President, Research and Development and John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer

 
Webcast link:    https://journey.ct.events/view/91b61a4f-e373-4b1c-9515-904d57eaa26e  
     

Panel

 

Date:

Wednesday, September 15, 2021

Time:

Available on-demand starting at 12:00 p.m. Eastern Time (ET)

Panel Title:

Best Practices – Planning for the Next Pandemic

Moderator:

Scott Gottlieb, M.D., Physician; Former Commissioner FDA

Panelist:

John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer

Webcast link:    https://journey.ct.events/view/df4da74c-0a2c-499c-a5be-13f994a0d28f
Why invest with us

We are a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.

For much of my four-decade career, I’ve worked with biotech companies trying to solve significant health challenges, including HIV. Novavax is uniquely positioned to help end this pandemic with our protein-based vaccine. I believe in NVX-CoV2373 so much.

I came out of retirement to join the fight.

Lisa Dunkle
Vice President, Global Medical Lead for Coronavirus Vaccine

Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.

Go to email subscription 

Investor inquiries

Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.